Category: News from Europe
AI-Based Pharma Startup BenevolentAI worth $2 Billion Raises $115 M Funding
UK-based BenevolentAI raised one of the largest fundings in AI pharmaceutical field. The company is significantly disrupting the pharma industry which spends $180 billion in a year on R&D.
‘Breath Biopsy’ Stands in Competition with ‘Liquid Biopsy’ as Next-Gen Cancer Diagnostics
KEY POINTS Breath Biopsy analyzes individual’s breath for biomarkers, signifying the metabolic conditions and cancer diagnosis of the person. GlaxoSmithKline ...
Merck Spin-off ObsEva’s Nolasiban Benefits Pregnancy in Women after IVF
KEY POINTS ObsEva’s oral drug, nolasiban demonstrated ongoing pregnancy benefit in women undergoing IVF or other assisted reproductive technology (ART) ...
Roche’s New Candidate Shows Superior Results than Lucentis in DME Patients
Roche’s investigational candidate RG7716 showed “clinically meaningful” and “statistically significant” improvements in gaining visual acuity in patients with diabetic macular ...
J&J Establishes First JLABS in Europe to Help Healthcare Startups
KEY POINTS First JLABS established in Europe at the Beerse Janssen R&D Campus. Belgium-based JLINX incubator will transition to global ...
FDA Approves First Novel Drug in 2018, Treats Rare Pancreatic Cancer
KEY POINTS The new drug approved by FDA targets hard-to-treat, a rare form of pancreatic cancer. It is the same ...
CGRP Inhibitors: New Migraine Preventive Treatments Coming Soon to the Market
KEY POINTS New treatment option- anti-CGRP drugs, to prevent a migraine is expected to reach the market in 2018. Allergan’s ...